Cargando…

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study

BACKGROUND: The treatment for brain metastases in small cell lung cancer (SCLC) is still controversial. The purpose of this study was to compare different brain radiotherapy treatments on SCLC patients with brain metastases. METHODS: In this multi-center retrospective study, SCLC patients who had un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Meng, Jiang, Aijun, Liu, Wenju, Sheng, Yanxing, Zeng, Haiyan, Liu, Ning, Gao, Qingxiao, Wang, Yong, Yu, Jinming, Yuan, Shuanghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093941/ https://www.ncbi.nlm.nih.gov/pubmed/32213185 http://dx.doi.org/10.1186/s13014-020-01509-3

Ejemplares similares

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases
por: Jiang, Aijun, et al.
Publicado: (2019)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Magnetic resonance imaging evaluation of treatment efficacy and prognosis for brain metastases in lung cancer patients after radiotherapy: A preliminary study
por: Liu, Yuhui, et al.
Publicado: (2018)

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
por: Chen, Yuanbin, et al.
Publicado: (2022)

Risk factors for brain metastases after prophylactic cranial irradiation in small cell lung cancer
por: Zeng, Haiyan, et al.
Publicado: (2017)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting
por: Lekic, Mirko, et al.
Publicado: (2012)

Organoids as a Systems Platform for SCLC Brain Metastasis
por: Quaranta, Vito, et al.
Publicado: (2022)

Upfront brain radiotherapy improves intracranial progression-free survival but not overall survival in lung adenocarcinoma patients with brain metastases: a retrospective, single-institutional analysis from China
por: Jiang, Aijun, et al.
Publicado: (2022)

Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer
por: Ge, Xiao-hui, et al.
Publicado: (2013)

Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2014)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease
por: Marcrom, Samuel R., et al.
Publicado: (2019)

Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases
por: Ni, Lingqin, et al.
Publicado: (2014)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer
por: Zeng, Haiyan, et al.
Publicado: (2019)

Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
por: Liu, Tingting, et al.
Publicado: (2015)

Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)

Pathology and Classification of SCLC
por: Raso, Maria Gabriela, et al.
Publicado: (2021)

Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions
por: Wang, Xiaoliang, et al.
Publicado: (2023)

Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma – final results of the BRAIN-RT trial
por: Hauswald, Henrik, et al.
Publicado: (2019)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Whole‐brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non‐small cell lung cancer: A single‐institution study
por: Qing, Dong, et al.
Publicado: (2019)

Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment
por: Khan, Naveed Ullah, et al.
Publicado: (2021)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
por: Hauswald, Henrik, et al.
Publicado: (2013)

Survival and quality of life after whole brain radiotherapy with 3D conformal boost in the treatment of brain metastases
por: Suteu, Patricia, et al.
Publicado: (2019)

The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
por: Fukumoto, Takeshi, et al.
Publicado: (2022)

Peritumoral Brain Edema in Metastases May Be Related to Glymphatic Dysfunction
por: Toh, Cheng Hong, et al.
Publicado: (2021)

What Are the Biomarkers for Immunotherapy in SCLC?
por: Longo, Vito, et al.
Publicado: (2021)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases
por: Antelo, Gabriela, et al.
Publicado: (2023)

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
por: Akamatsu, Hiroaki, et al.
Publicado: (2021)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
por: Ono, Takashi, et al.
Publicado: (2022)

(125)I Radiotherapy combined with metronomic chemotherapy may boost the abscopal effect, leading to complete regression of liver metastasis in an SCLC patient with a 58.5-month OS: a case report
por: Lu, Linlin, et al.
Publicado: (2023)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gobfpcg60dcn2qa5vacmecpph9